2019 IPO

TP Therapeutics Stock

TP Therapeutics is a structure-based drug design pharmaceutical company

Sign up today and learn more about TP Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About TP Therapeutics Stock

TP Therapeutics, Inc. is a structure-based drug design pharmaceutical company founded by Dr. J. Jean Cui, the lead inventor of Pfizer's Xalkori(TM) (generic name: crizotinib), the precision oncology drug for non-small cell lung cancer (NSCLC). Xalkori(TM) was approved by US Food and Drug Administration on August 26th, 2011.

Funding History

January 2014$1.4M
March 2016$18.0M
May 2017$45.0M
October 2018$80.0M


Founder & CSO

J. Jean Cui

Senior Vice President, Clinical Operations and Regulatory Affairs

John K.C. Lim


Athena Countouriotis

Co-founder, Chairman, President, and CEO

Y. Peter Li

Vice President of Pre-Clinical Development

Jeffrey P. Whitten

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 300K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: